News and actuality

Current press releases, talks and reports

Comprehensive Molecular Profiling for Targeted Cancer Therapy – Interview with Markus Tiemann, MD

Markus Tiemann, MD, is the Chief Executive Officer and founder of the Institute for Hematopathology in Hamburg, Germany. During the Annual Meeting of the American Society of Clinical Oncology meeting in June 2017 in Chicago, Dr. Markus Tiemann discussed molecular pathology, clinical decision-making in oncology, and his recent collaboration with the Siemens Healthineers’ daughter NEO New Oncology in the field of molecular tumor diagnostics. 

Link to interview






Office: +49.221.888.23 80


NEO New Oncology GmbH
Gottfried-Hagen-Str. 20
51105 Cologne

ImprintPrivacy policy uses cookies to make the website more user-friendly. By continuing to use the website, you agree to the use of cookies. If you do not agree to the storage of cookies, you will find further information HERE.